73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Study confirms new prognostic markers for triple negative breast cancer

Study confirms new prognostic markers for triple negative breast cancer

by SWOGCredit: CC0 Public DomainPhysicians who treat patients with triple negative breast cancer have two new ways to predict which patients may benefit most from the well-established post-surgery tre

Study confirms new prognostic markers for triple negative breast cancer

by SWOGCredit: CC0 Public DomainPhysicians who treat patients with triple negative breast cancer have two new ways to predict which patients may benefit most from the well-established post-surgery tre
Scientists unravel mystery of drug response in small cell lung cancer

Scientists unravel mystery of drug response in small cell lung cancer

by University of CologneTumor samples and clinical history of 65 patients with SCLC. a, Tumor sites sampled from 65 patients with SCLC. Frequently sampled sites are highlighted in bold. Tumors we

Scientists unravel mystery of drug response in small cell lung cancer

by University of CologneTumor samples and clinical history of 65 patients with SCLC. a, Tumor sites sampled from 65 patients with SCLC. Frequently sampled sites are highlighted in bold. Tumors we
Heart disease prevention is particularly important in cancer patients

Heart disease prevention is particularly important in cancer patients

by Johannes Angerer,Medical University of ViennaBaseline cardiovascular toxicity risk assessment checklist. BNP, B-type natriuretic peptide; cTn, cardiac troponin; CTR-CVT, cancer therapy-relate

Heart disease prevention is particularly important in cancer patients

by Johannes Angerer,Medical University of ViennaBaseline cardiovascular toxicity risk assessment checklist. BNP, B-type natriuretic peptide; cTn, cardiac troponin; CTR-CVT, cancer therapy-relate
Experimental drug to treat liver cancer shows evidence of activity with manageable side effects

Experimental drug to treat liver cancer shows evidence of activity with manageable side effects

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainA new drug that inhibits an enzyme playing a crucial role in cell division and growth has shown signs of a

Experimental drug to treat liver cancer shows evidence of activity with manageable side effects

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainA new drug that inhibits an enzyme playing a crucial role in cell division and growth has shown signs of a
Taxane-induced peripheral neuropathy in breast cancer: Frequent, clinically significant, and worse with paclitaxel

Taxane-induced peripheral neuropathy in breast cancer: Frequent, clinically significant, and worse with paclitaxel

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainChemotherapy-induced peripheral neuropathy (CIPN)—nerve pain, tingling, or numbness in the hands or feet—is a common side effect of cer

Taxane-induced peripheral neuropathy in breast cancer: Frequent, clinically significant, and worse with paclitaxel

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainChemotherapy-induced peripheral neuropathy (CIPN)—nerve pain, tingling, or numbness in the hands or feet—is a common side effect of cer
Experimental test promises to predict side-effects and cancer's return in patients treated with immunotherapy

Experimental test promises to predict side-effects and cancer's return in patients treated with immunotherapy

by NYU Langone HealthCancer cell during cell division. Credit: National Institutes of HealthA single research test has the potential to predict which patients treated with immunotherapies—which h

Experimental test promises to predict side-effects and cancer's return in patients treated with immunotherapy

by NYU Langone HealthCancer cell during cell division. Credit: National Institutes of HealthA single research test has the potential to predict which patients treated with immunotherapies—which h
Age impacts pharmacogenomics and treatment outcomes for most common form of leukemia

Age impacts pharmacogenomics and treatment outcomes for most common form of leukemia

bySt. Jude Children's Research HospitalJun J. Yang, PhD, St. Jude Departments of Pharmacy and Pharmaceutical Sciences and Oncology and first co-authors Zhenhua Li, PhD, and Satoshi Yoshimura

Age impacts pharmacogenomics and treatment outcomes for most common form of leukemia

bySt. Jude Children's Research HospitalJun J. Yang, PhD, St. Jude Departments of Pharmacy and Pharmaceutical Sciences and Oncology and first co-authors Zhenhua Li, PhD, and Satoshi Yoshimura
Study answers questions about long-term survivorship following CAR T treatment

Study answers questions about long-term survivorship following CAR T treatment

byH. Lee Moffitt Cancer Center & Research InstituteHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Axicabtagene cilole

Study answers questions about long-term survivorship following CAR T treatment

byH. Lee Moffitt Cancer Center & Research InstituteHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Axicabtagene cilole
Invasive breast cancer risk down for female child cancer survivors

Invasive breast cancer risk down for female child cancer survivors

For childhood cancer survivors, the rates of invasive breast cancer have decreased over time, according to a study published online Oct. 13 inJAMA Oncology.Tara O. Henderson, M.D., M.P.H., from

Invasive breast cancer risk down for female child cancer survivors

For childhood cancer survivors, the rates of invasive breast cancer have decreased over time, according to a study published online Oct. 13 inJAMA Oncology.Tara O. Henderson, M.D., M.P.H., from
Cancer drug approved for NHS use in England gives some multiple myeloma patients another option

Cancer drug approved for NHS use in England gives some multiple myeloma patients another option

by Cancer Research UKCredit: CC0 Public DomainA drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treat

Cancer drug approved for NHS use in England gives some multiple myeloma patients another option

by Cancer Research UKCredit: CC0 Public DomainA drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treat
New ovarian cancer screening technique shows reduced false negatives compared to CA125 method

New ovarian cancer screening technique shows reduced false negatives compared to CA125 method

by Justin Jackson , Medical XpressGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101061Researchers at the Department of Obstetrics and Gynecology, Peking

New ovarian cancer screening technique shows reduced false negatives compared to CA125 method

by Justin Jackson , Medical XpressGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101061Researchers at the Department of Obstetrics and Gynecology, Peking
Rucaparib efficacious in metastatic castration-resistant prostate cancer

Rucaparib efficacious in metastatic castration-resistant prostate cancer

by Elana GotkineFor patients with metastatic castration-resistant prostate cancer, treatment with rucaparib is associated with significantly longer duration of imaging-based progression-free survival

Rucaparib efficacious in metastatic castration-resistant prostate cancer

by Elana GotkineFor patients with metastatic castration-resistant prostate cancer, treatment with rucaparib is associated with significantly longer duration of imaging-based progression-free survival